Consort Medical plc (CSRT) Jumps 1.63% on Jun 17

June 17, 2018 - By Henry Gaston

Shares of Consort Medical plc (LON:CSRT) last traded at 1250, representing a move of 1.63%, or 20 per share, on volume of 32,712 shares. After opening the trading day at 1250, shares of Consort Medical plc traded in a close range. Consort Medical plc currently has a total float of 489,848 shares and on average sees 28,901 shares exchange hands each day. The stock now has a 52-week low of 1020 and high of 1270.

The Evolution Of The LSE In 200 Years

Trade and commerce in the UK can be traced back to hundreds of years ago. Today, it plays an important role in global trade and commerce as one of the biggest and most significant contributors.

It is undeniable that the UK is one of the most developed countries in the world as well. Because of this and its constant strive for progress, the global economy is continuously shaping up to become bigger and better through the years.

London Stock Exchange (LSE)

The LSE is the main stock exchange in the UK. It had been founded in 1801, making it one of the oldest stock exchanges in the world.

Today, the LSE is considered as the biggest stock exchange in Europe and the third biggest one in the world. As of the end of the third quarter, more than 2,290 companies are listed on the LSE, bringing its total market capitalization to more than ‘6 trillion.

Presently, the LSE Group (LSEG), which had been founded in October 2007 following the merger of the LSE and the Borsa Italiana, operates the LSE.

Financial Times Stock Exchange (FTSE) 100 Index

The FTSE 100 is the benchmark blue-chip index in the UK. It measures the top 100 companies listed on the LSE as a free-float, market-capitalization-weighted index. As of September, the FTSE 100 has a total market capitalization of ‘1.70 trillion.

The FTSE 100 had been founded on January 3, 1984 with a base value of 1,000 points. It is currently operated by the FTSE Group, a subsidiary of LSEG. Consort Medical plc is a stock traded on the U.K’s stock exchange.

Most of the components of the FTSE 100 are international companies, which is why it is not a strong indicator of the UK economy. Nonetheless, it is a strong indicator of the LSE, representing more than 80% of the total market capitalization on the LSE. The FTSE 250, which measures the top 250 companies listed on the LSE, is a stronger indicator of the UK economy than the FTSE 100 because of its broad nature and most of its components being domestic companies. Consort Medical plc has relatively good liquidity.

The FTSE 100 is rebalanced quarterly’ specifically every Wednesday immediately following the first Friday of March, June, September, and December. Components that have fallen short of the inclusion requirements are dropped to give way to those that have met all the said requirements.

The FTSE 100 had reached its all-time low of 427.50 points in February 1978; and its all-time high of 7,103.98 points in April 2015. Meanwhile, its best intraday high of 7,129 points had been reached on October 11.

Many investors are banking on the promising growth of the European economy. Amid the pressing concerns of today, it is still ideal for investors to penetrate European equity markets such as that of the UK.

Boasting with full potentials to realize its growth prospects, the UK economy guarantees meaningful investment returns for domestic and international investors alike. Those who still doubt this can simply look back through the hundreds of years that the UK economy had been tried and tested. Professional analysts might be interested how this will affect Consort Medical plc.

Consort Medical plc, a contract development and manufacturing organization, provides drugs and premium drug delivery devices. The company has market cap of 612.31 million GBP. It operates through two divisions, Bespak and Aesica. It has a 31.33 P/E ratio. The firm designs, develops, and makes medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.